Skip to content

HYPERION-TransCare (Heading to ContinuitY of Prescribing in EldeRly with MultImOrbidity iN Transitional Care) - a clusterrandomized and controlled feasibility study to test the practicability and implementability of a complex intervention and study design

HYPERION-TransCare (Heading to ContinuitY of Prescribing in EldeRly with MultImOrbidity iN Transitional Care) - a clusterrandomized and controlled feasibility study to test the practicability and implementability of a complex intervention and study design - HYPERION-TransCare

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027649
Enrollment
200
Registered
2022-01-19
Start date
2022-03-26
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multimorbidity Multimedication

Interventions

Group 1: In the intervention group, the testing and implementation of the participatory developed "hospital referral management" takes place in the 6-month intervention phase. Prospective data collect

Sponsors

Medizinische Fakultät Carl Gustav Carus an der TU Dresden Bereich Allgemeinmedizin/ Medizinische Klinik und Poliklinik III
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Age: 65+ years, = 2 long-term diagnoses, Taking = 5 long-term medication, = 1 previous hospital stay in the last 12 months, The patient must be able to take part in written and telephone surveys (the patient can be supported by relatives, acquaintances ..)

Exclusion criteria

Exclusion criteria: Prefinal disease state, Patient in the nursing home, Severe mental illness (spectrum ICD-10-F diagnoses), Planned long-term admission in the nursing home Patient with legal guardian

Design outcomes

Primary

MeasureTime frame
Combined primary endpoint (testing for the main study): health-related patient outcomes: Hospitalisation (FIMA), falls (standardised documentation) and mortality (standardised documentation) at t0 (baseline) and t1 (follow-up after 6 months) in the intervention group compared to the control group. The combined primary endpoint is recorded by information from patients or enquiries in the general practitioner's office.

Secondary

MeasureTime frame
Exploratory examination of the effect of the complex intervention on: a) Improvement of the medication- and treatment-relevant information situation as well as increase of health literacy among patients b) Improvement of the medication-related information situation in the general practice. Target parameters: a) Improvement of health literacy and satisfaction with the information situation among patients* between the survey times t0 and t1 in the intervention group compared to the control group. The following measures will be collected: - Health literacy: Health Literacy Questionnaire - German (HLQ-G) - Satisfaction with medication-related information: Satisfaction with Information about Medicines Scale (SIMS-D), questions about the medication plan (survey) b) Improvement of the information situation in GP practices between t0 and t1 in the intervention group compared to the control group. - Information on the care situation: questionnaire on the use of medical and non-medical care services in old age (FIMA) Comparison of the information provided by patients with that provided by the GP practice. - Information on medication: Checking the completeness of the medication information by comparing the information provided by patients (survey) and the information in the GP practice (medication plan). Process evaluation: A process evaluation accompanying the entire study assesses the feasibility and implementability of the intervention and the study design. On the other hand, parameters are collected and analysed that could have an influence on the results. The process evaluation is conducted with a mix of methods including interviews, questionnaires and standardised project documentation. The methodology of the process evaluation follows the framework for designing and reporting on process evaluations of cluster randomized trials (Grant et al 2013) and the Consolidated Framework of Implementation Research (CFIR, Damschroder et al 2009).

Countries

Germany

Contacts

Public ContactFranziska Brosse

Medizinische Fakultät Carl Gustav Carus an der TU DresdenBereich Allgemeinmedizin/ Medizinische Klinik und Poliklinik III

SaxoN@uniklinikum-dresden.de0351 458 89-234

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 12, 2026